Symbiotec Pharmalab Ltd.
SYMBIOTEC
Symbiotec Pharmalab Ltd.
SYMBIOTEC
Symbiotec Pharmalab Ltd. Share Price
1,098.00 +4.20 (+0.38%)Share Price Today – Symbiotec Pharmalab Ltd.
As of October 9, 2026, Symbiotec Pharmalab Ltd. share price is ₹1,098.00. The stock opened at ₹1,081.00 and closed at ₹1,093.80 in the previous session. During the trading session, the share price moved between ₹1,078.10 and ₹1,112.50. Over the last 52 weeks, the stock has recorded a low of ₹934.20 and a high of ₹1,246.00. In terms of performance, the stock has delivered 10.5% returns over the past six months and 10.5% returns over the last year.
About the company
Fundamentals
Market Cap₹7,012Cr | EPS₹19.10 |
Book Value/Share₹178.98 | Industry P/E (TTM)46.00 |
P/B Ratio8.27 | Long Term D/E0.66 |
ROE12.65% | Dividend Yield (TTM)0.00% |
Sector P/E Ratio (TTM)39.63 | Sector P/B Ratio5.35 |
FAQs on Symbiotec Pharmalab Ltd.
The share price of Symbiotec Pharmalab Ltd. is ₹1,098.00 on NSE as of 9/10/2026, 2:20:20 pm. Share prices may change frequently due to market movements.
The market capitalisation of Symbiotec Pharmalab Ltd. is ₹7,012Cr as of 9/10/2026, 2:20:20 pm
The current Price to Earnings (P/E) ratio of Symbiotec Pharmalab Ltd. is 0.00 as of 9/10/2026, 2:20:20 pm
The Price to Book (P/B) ratio of Symbiotec Pharmalab Ltd. stands at 8.28 as of 9/10/2026, 2:20:20 pm
Symbiotec Pharmalab Ltd. reported an ROE of 12.65% for the last reported financial year on a consolidated account basis.
As of 9/10/2026, 2:20:20 pm, Symbiotec Pharmalab Ltd.’s shareholding pattern is: promoters hold undefined%, FIIs hold undefined%, DIIs hold undefined%, and public shareholders hold undefined%.
The 52-week high of Symbiotec Pharmalab Ltd. is ₹1,246.00 and the 52-week low is ₹934.20 as of 9/10/2026, 2:20:20 pm.
The earnings per share (EPS) of Symbiotec Pharmalab Ltd. is -- for the quarter ended Sep 2026.
The stock symbol of Symbiotec Pharmalab Ltd. is SYMBIOTEC.
You can buy Symbiotec Pharmalab Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Symbiotec Pharmalab Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Jun 2026 | Q/Q Change |
|---|---|---|
| Operating Revenue | 218.15 | -11.05% |
| Other Income | 0.34 | +112.50% |
| Total Income | 218.49 | -10.97% |
| Total Expenditure | 172.95 | -5.57% |
| EBIDT | 45.54 | -26.84% |
| Depreciation | 21.82 | +10.48% |
| Interest | 6.18 | -14.88% |
| Tax | 3.47 | -54.99% |
| Net Profit | 14.06 | -48.89% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 485.54 |
| Total Non-Current Assets | 1,295.25 |
| Fixed assets | 1,184.81 |
| Total Assets | 1,780.79 |
| Total Current liabilities | 527.56 |
| Total Non Current Liabilities | 103.64 |
| Total Equity Plus Liabilities | 1,780.79 |
| Total Shareholder Funds | 1,149.73 |
| Total Debt to Equity | 34.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 174.59 |
| Cash from Financing Activities | 35.99 |
| Cash from Investing Activities | -226.93 |
| Net Cash Flow | -16.35 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages0
Bearish Moving Averages8
5 Day
1,149.3010 Day
1,115.1020 Day
1,108.00Indicators
RSI (14)
47.98MACD (12, 26)
--MACD Signal Line (9)
--MFI (14)
63.94ATR (14)
67.37ADX (14)
--ROC (21)
-0.45ROC (125)
--Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages0
Bearish Moving Averages8
5 Day
1,149.3010 Day
1,115.1020 Day
1,108.00Indicators
RSI (14)
47.98MACD (12, 26)
--MACD Signal Line (9)
--MFI (14)
63.94ATR (14)
67.37ADX (14)
--ROC (21)
-0.45ROC (125)
--Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Symbiotec Pharmalab Ltd.
SYMBIOTEC
Open Price | 1,081.00 |
Previous Close | 1,093.80 |
Volume | 2,94,567 |
Average Price | 1,092.98 |
Upper Circuit | 1,312.50 |
Lower Circuit | 875.10 |
Historical Performance
| NA | 1 Day |
| NA | 5 Days |
| NA | 1 Month |
| NA | 3 Months |
| NA | 1 Year |
| NA | 5 Years |
| NA | 10 Years |